Medifast, Inc. (MED) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MED Revenue Growth
Revenue Breakdown (FY 2017)
MED's revenue distribution by segment and geography for fiscal year 2017
By Product/Segment
MED Revenue Analysis (2014–2025)
As of May 7, 2026, Medifast, Inc. (MED) generated trailing twelve-month (TTM) revenue of $346.1 million, reflecting significant decline in growth of -34.3% year-over-year. The most recent quarter (Q1 2026) recorded $76.0 million in revenue, up 1.3% sequentially.
Looking at the longer-term picture, MED's 5-year compound annual growth rate (CAGR) stands at -16.2%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $1.60 billion in 2022.
Revenue diversification analysis shows MED's business is primarily driven by Optavia (85%), Medifast Direct (11%), and Franchise Weight Control Centers (4%). With over half of revenue concentrated in Optavia, the company maintains significant focus in this area while developing other growth vectors.
When compared to Consumer Cyclical sector peers including HIMS (+59.0% YoY), NUS (-12.1% YoY), and USNA (+8.3% YoY), MED has underperformed the peer group in terms of revenue growth. Compare MED vs HIMS →
MED Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MEDCurrent | $346M | -34.3% | -16.2% | -3.7% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% | |
 NUS | $1.5B | -12.1% | -10.5% | 4.4% | |
 USNA | $925M | +8.3% | -4.0% | 5.5% | |
 RVLV | $1.2B | +10.0% | +16.1% | 6.1% | |
 WW | $711M | -7.0% | -12.4% | 6.5% |
MED Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $385.8M | -36.0% | $275.2M | 71.3% | $-14,213,000 | -3.7% |
| 2024 | $602.5M | -43.8% | $444.6M | 73.8% | $2.9M | 0.5% |
| 2023 | $1.07B | -32.9% | $775.9M | 72.4% | $126.4M | 11.8% |
| 2022 | $1.60B | +4.8% | $1.14B | 71.3% | $184.8M | 11.6% |
| 2021 | $1.53B | +63.2% | $1.13B | 73.9% | $216.2M | 14.2% |
| 2020 | $934.8M | +31.0% | $697.8M | 74.6% | $134.2M | 14.4% |
| 2019 | $713.7M | +42.4% | $536.9M | 75.2% | $91.0M | 12.8% |
| 2018 | $501.0M | +66.1% | $379.9M | 75.8% | $69.1M | 13.8% |
| 2017 | $301.6M | +9.8% | $227.8M | 75.5% | $39.6M | 13.1% |
| 2016 | $274.5M | +0.6% | $205.7M | 74.9% | $26.9M | 9.8% |
See MED's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MED Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MED vs AMZN
Side-by-side business, growth, and profitability comparison vs Amazon.com, Inc..
Start ComparisonMED — Frequently Asked Questions
Quick answers to the most common questions about buying MED stock.
Is MED's revenue growth accelerating or slowing?
MED revenue declined -34.3% year-over-year, contrasting with the 5-year CAGR of -16.2%. TTM revenue fell to $346M. This reverses the prior growth trend.
What is MED's long-term revenue growth rate?
Medifast, Inc.'s 5-year revenue CAGR of -16.2% reflects the variable expansion pattern. Current YoY growth of -34.3% is below this long-term average.
How is MED's revenue distributed by segment?
MED reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.